관절통 주사제 시장 규모, 점유율, 성장 분석 : 유형별, 관절별, 용도별, 지역별 - 업계 예측(2026-2033년)

Joint Pain Injections Market size was valued at USD 7.31 Billion in 2024 and is poised to grow from USD 7.88 Billion in 2025 to USD 14.26 Billion by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The global market for Joint Pain Injections is experiencing robust expansion, driven by the rising incidence of joint disorders, an aging population, and a growing preference for minimally invasive treatment solutions. These injections offer targeted pain alleviation and improved joint functionality, serving as a viable alternative to surgical options. Continuous advancements in injection technology and innovative formulations are enhancing treatment efficacy and longevity. Furthermore, the increasing acceptance of regenerative medicine and biologic injections is influencing market dynamics. Nevertheless, challenges such as high injection costs, limited reimbursement options, and potential adverse effects may pose barriers to growth in this sector. Overall, the demand for effective joint pain management continues to reshape the joint pain injections landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Joint Pain Injections market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Joint Pain Injections Market Segments Analysis

Global Joint Pain Injections Market is segmented by type, joint, end use and region. Based on type, the market is segmented into hyaluronic acid injections, corticosteroid injections, platelet rich plasma injections and others. Based on joint, the market is segmented into knee, shoulder & elbow, ankle & hip and other joint types. Based on end use, the market is segmented into hospitals, clinics and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Joint Pain Injections Market

A significant factor fueling the Joint Pain Injections market is the rising prevalence of joint disorders. As conditions like osteoarthritis and rheumatoid arthritis become more common, there is a heightened demand for effective pain relief options, particularly joint pain injections. Contributing to this trend are the growing numbers of elderly individuals, increasingly sedentary lifestyles, and a surge in sports-related injuries, all of which create a pressing need for reliable pain management solutions. This blend of demographic changes and lifestyle factors is driving the market forward, underscoring the importance of innovative treatment options for individuals suffering from joint pain.

Restraints in the Joint Pain Injections Market

One significant constraint facing the global Joint Pain Injections market is the elevated cost associated with these treatments. Many individuals find joint pain injections to be prohibitively expensive, particularly those lacking adequate insurance coverage. This financial barrier can restrict access to necessary care, especially for patients in developing regions where healthcare affordability poses a considerable challenge. Furthermore, the complexities related to reimbursement policies and regulatory requirements in various countries can further impede market expansion, ultimately limiting the availability and adoption of joint pain injection therapies for those in need.

Market Trends of the Joint Pain Injections Market

The Joint Pain Injections market is experiencing a notable trend toward the increasing adoption of minimally invasive procedures, reflecting a shift in patient preferences and healthcare practices. With a growing focus on non-surgical alternatives for managing joint pain, injections are becoming a favored treatment method due to their associated benefits. Patients appreciate the shorter recovery times, reduced risk of complications, and decreased postoperative discomfort that these injections offer. Administered in outpatient settings, joint injections provide targeted relief, catering to individual needs and enabling personalized treatment approaches. This trend underscores the broader movement towards patient-centric care, emphasizing effective, accessible, and tailored interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Joint Pain Injections Market Size by Type & CAGR (2026-2033)

• Market Overview
• Hyaluronic Acid Injections
• Corticosteroid Injections
• Platelet Rich Plasma Injections
• Others

Global Joint Pain Injections Market Size by Joint & CAGR (2026-2033)

• Market Overview
• Knee
• Shoulder & Elbow
• Ankle & Hip
• Other Joint Types

Global Joint Pain Injections Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Other

Global Joint Pain Injections Market Size & CAGR (2026-2033)

• North America (Type, Joint, End Use)
  • USA
  • Canada
• Europe (Type, Joint, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Joint, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Joint, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Joint, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chugai Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seikagaku Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flexion Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations